Small airway inflammation and dysfunction will be measured in 40 children and 40 adults with asthma before and after 8 weeks of treatment with inhaled budesonide. The same measurements will be conducted once in 80 age and sex matched healthy controls.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
160
Small airway inflammation and dysfunction will be measured using the above mentioned tests.
Allergy Centre, Tampere University Hospital
Tampere, Finland
RECRUITINGPrevalence of small airway inflammation (measured by peripheral NO output) in untreated asthma
Change in peripheral NO output
Time frame: Baseline
Prevalence of small airway dysfunction (measured by peripheral airway resistance) in untreated asthma
Change in peripheral airway resistance
Time frame: Baseline
Difference in Eosinophil Cationic Protein (ECP)/B-Eos ratio between asthmatics and controls
ECP/B-Eos ratio will calculated by dividing serum level of ECP by peripheral blood eosinophil count.
Time frame: Baseline
Correlation between ECP/B-Eos ratio and peripheral NO output in untreated asthma
ECP/B-Eos ratio will be calculated as above. Peripheral exhaled NO output will be calculated based on exhaled NO measurement at multiple flow rates.
Time frame: Baseline
Correlation between ECP/B-Eos ratio and peripheral airway resistance in untreated asthma
ECP/B-Eos ratio will be calculated as above. Peripheral airway resistance will be calculated as R5-R20 based on impulse oscillometry.
Time frame: Baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.